Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

DiaMedica Therapeutics (DMAC) announced the peer-reviewed publication entitled: “Recombinant human tissue kallikrein-1 for treating acute ...

Cancer cells work together to source nutrients from their environment -- a cooperative process that was previously overlooked by scientists but may be a promising target for treating cancer.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.

A combination of higher-than-average rainfall and temperatures in coffee-producing regions caused major problems for farmers ...

Boryung announced on the 18th the launch of 'Ravetricks Capsule', a combination of aspirin and rabeprazole. Ravetricks is a ...

A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in ...

Dr. Tim Gershon, a pediatric neurologist at Children's Healthcare of Atlanta and director of Emory University's Children's Center for Neurosciences Research, says he and his team found that a new drug ...